Accès gratuit
Numéro
Med Sci (Paris)
Volume 24, Numéro 12, Décembre 2008
Page(s) 1017 - 1019
Section Nouvelles
DOI https://doi.org/10.1051/medsci/200824121017
Publié en ligne 15 décembre 2008
  1. Simpson JY. Contributions to the pathology and treatment of diseases of the uterus. London and Edinburgh Monthly Journal of Medical Science 1843; 3 : 1008–11.
  2. Poiseuille J. Recherches sur la force du coeur aortique. Archives Générales de Médecine 1828; 8 : 550–4.
  3. Korotkov N. On methods of studying blood pressure Izvest. Imp. Voyenno-Med. Akad St Petersburgh 1905; 11 : 365.
  4. Purkerson ML, Vekerdy L. A history of eclampsia, toxemia and the kidney in pregnancy. Am J Nephrol 1999; 19 : 313–9.
  5. Hiby, SE, Walker JJ, O’shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200 : 957–65.
  6. Redman, CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308 : 1592–4.
  7. Germain SJ, Sacks GP, Sooranna SR, et al. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178 : 5949–56.
  8. Van Dijk M, Poutsma A, Könst AA, et al. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet 2005; 37 : 514–9.
  9. Kivinen K, Peterson H, Hiltunen L, et al. Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample. Eur J Hum Genet 2007; 15 : 494–7.
  10. Berends AL, Bertoli-Avella AM, de Groot CJ, et al. STOX1 gene in pre-eclampsia and intrauterine growth restriction. Br J Obst Gynecol 2007; 114 : 1163–7.
  11. Iglesias-Platas I, Monk D, Jebbink J, et al. STOX1 is not imprinted and is not likely to be involved in preeclampsia. Nat Genet 2007; 39 : 279–80.
  12. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12 : 642–9.
  13. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355 : 992–1005.
  14. Kanayama N, Takahashi K, Matsuura T, et al. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 2002; 8 : 1129–35.
  15. Kanasaki K, Palmsten K, Sugimoto H, et al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008; 453 : 1117–21.
  16. Chelbi ST, Mondon F, Jammes H, et al. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension 2007; 49 : 76–83.
  17. Zhou CC, Zhang Y, Irani RA, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 2008; 14 : 855–62.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.